ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983

Sequestration: $1.71 Billion Cut to NIH Budget Will Reduce Number of RPGs

May 17, 2013

Professional Societies: ACCI Selects UPCI To Manage Operations; Elects New Officers

December 3, 1999

Cervical Screening Should Emphasize Older Women, ASP Members Told

March 14, 1986

Diane Fink Accepts VP Job With ACS

April 3, 1981

NCI plans 18 percent budget cuts for large R01s, smaller cuts to other research project grants. NCI treatment division director Ellen Feigal accepts position with Translational Genomics Research Institute in Phoeniz, Ariz.

March 12, 2004